Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2022-11-10 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2022-11-10 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is a notice about a revised schedule for a conference call (Con Call) meeting related to the 2QFY 2022-23 earnings of Indoco Remedies Limited. It is addressed to stock exchanges and mentions the date and time of the earnings call, company participants, and dial-in details. There is no actual financial data or detailed financial report included. The document serves as an announcement or invitation for the earnings call rather than the earnings release itself or a transcript. Given the content and length (3777 characters), it is not a full earnings release or transcript but an announcement related to the earnings call schedule. Therefore, the most appropriate classification is Call Transcript (CT) since it is about the earnings conference call, but since it is only the schedule notice and not the transcript, the best fit is Regulatory Filings (RNS) as a general regulatory announcement about the call schedule. However, since the document specifically announces the schedule of the earnings conference call, it aligns best with Call Transcript (CT) category as it relates directly to the earnings call event. Confidence is high due to clear references to the earnings call schedule and participants.
2022-11-08 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is a notice about the schedule of a conference call (Con Call) for Indoco Remedies Limited's 2QFY 2022-23 earnings. It includes details such as date, time, dial-in numbers, company participants, and contact information. There is no actual financial data or detailed financial report included, only an announcement of the upcoming earnings call. The document length is 3774 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or schedule, but since it does not contain the transcript itself, it is an announcement of the call. Given the options, the closest and most appropriate classification is Call Transcript (CT) as it relates directly to the earnings call event.
2022-11-07 English
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ended September 30, 2022. It does not contain the financial results themselves, only an announcement of the meeting date and related compliance information. The document length is only 1427 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of a report to be released later, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2022-10-20 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) referencing Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It encloses a certificate from the Registrar and Share Transfer Agent for the quarter ended September 30, 2022. The document is short (1047 characters) and serves as an official notification or submission of a certificate rather than a full report or financial statement. It does not contain financial data or detailed analysis. This fits the profile of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-10-13 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 95% confidence The document is a notification addressed to stock exchanges about the schedule of an analyst/institutional investor meeting. It includes details about a virtual call with company executives to discuss business updates and outlook. There are no financial statements, detailed financial data, or comprehensive report content. The document is short (2720 characters) and serves as an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, it fits best as an Investor Presentation (IP) type, as it focuses on informing about a detailed presentation for investors regarding financials, strategy, and market position.
2022-10-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.